InsiderClue
Insiders · Profile

MAZELSKY JONATHAN JAY

President and CEO at Idexx Laboratories. Filing since 5 Aug 2019. CIK 0001556270

Company
Date
Role
Action
Shares
Amount
Of holding
IDXX Idexx Laboratories
26 Feb 2026
President and CEO
Sold at will
23,326
$15.34M
21.8%
IDXX Idexx Laboratories
6 Aug 2025
President and CEO
Sold at will
29,260
$18.49M
26.0%
IDXX Idexx Laboratories
7 Feb 2024
President and CEO
Sold at will
12,000
$6.87M
13.2%
IDXX Idexx Laboratories
4 Dec 2023
President and CEO
Sold at will
7,128
$3.66M
8.3%
IDXX Idexx Laboratories
31 Aug 2023
President and CEO
Sold at will
13,424
$6.87M
15.5%
IDXX Idexx Laboratories
14 Nov 2022
President & CEO
Sold, plan not stated
10,500
$4.56M
12.9%
IDXX Idexx Laboratories
7 Nov 2022
President & CEO
Sold, plan not stated
13,230
$5.06M
17.5%
IDXX Idexx Laboratories
16 Aug 2021
President & CEO
Sold, plan not stated
1,263
$850.41K
2.5%
IDXX Idexx Laboratories
13 Aug 2021
President & CEO
Sold, plan not stated
4,737
$3.20M
8.5%
IDXX Idexx Laboratories
17 Feb 2021
President & CEO
Sold, plan not stated
13,868
$7.45M
20.4%
IDXX Idexx Laboratories
5 Nov 2020
President & CEO
Sold, plan not stated
5,206
$2.44M
11.7%
IDXX Idexx Laboratories
5 Feb 2020
President & CEO
Sold, plan not stated
8,000
$2.22M
15.8%
IDXX Idexx Laboratories
5 Aug 2019
Interim President & CEO
Sold, plan not stated
10,000
$2.58M
30.1%
13 decisions on file.